Literature DB >> 28365853

Vitreous hemorrhage as an early sign of acute bacterial endophthalmitis following intravitreal ranibizumab injection.

Yishay Weill1, Koby Brosh2, Tamar Levi-Vineberg2, Joel Hanhart2.   

Abstract

PURPOSE: To report a case of acute bacterial endophthalmitis after antivascular endothelial growth factor injection with a rare presentation of vitreous hemorrhage.
METHODS: An 84-year-old woman presented with sudden painless vision loss in her left eye, 3 days after intravitreal ranibizumab injection for cystoid macular edema due to neovascular age-related macular degeneration. The patient was otherwise asymptomatic. Dense vitreous hemorrhage was observed. At follow-up the next day, the patient complained on severe left eye pain. After examination, acute endophthalmitis was diagnosed.
RESULTS: Intravitreal injection of vancomycin, ceftazidime and dexamethasone was performed. Vitreous and aqueous cultures grew Enterococcus faecalis. After treatment, the inflammation subsided but it took 3 months for the vitreous hemorrhage to totally resorb. Visual acuity was reduced to light perception.
CONCLUSIONS: Vitreous hemorrhage may be an atypical presentation of acute bacterial endophthalmitis occurring after intravitreal injection.

Entities:  

Keywords:  Antivascular endothelial growth factor; Endophthalmitis; Enterococcus faecalis; Intravitreal injection; Ranibizumab; Vitreous hemorrhage

Mesh:

Substances:

Year:  2017        PMID: 28365853     DOI: 10.1007/s10792-017-0505-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  9 in total

1.  Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients.

Authors:  John O Mason; Paul A Frederick; Michael G Neimkin; Milton F White; Richard M Feist; Martin L Thomley; Michael A Albert
Journal:  Retina       Date:  2010-10       Impact factor: 4.256

2.  Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Authors:  John B Fileta; Ingrid U Scott; Harry W Flynn
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2014 Mar-Apr       Impact factor: 1.300

3.  Fatal suppurative mesenteric thrombophlebitis caused by an Enterococcus faecalis highly resistant to aminoglycosides: case report.

Authors:  A Capone; M Cassone; D Tarasi; C Brandimarte; A Tarasi; M Galiè; M Venditti
Journal:  J Chemother       Date:  1998-04       Impact factor: 1.714

4.  Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.

Authors:  Shelley Day; Kofi Acquah; Prithvi Mruthyunjaya; Daniel S Grossman; Paul P Lee; Frank A Sloan
Journal:  Am J Ophthalmol       Date:  2011-06-12       Impact factor: 5.258

5.  Association between systemic anticoagulation and rate of intraocular hemorrhage following intravitreal anti-VEGF therapy for age-related macular degeneration.

Authors:  Joanna M Olson; Ingrid U Scott; Denise L Kerchner; Allen R Kunselman
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2013 Sep-Oct       Impact factor: 1.300

6.  Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.

Authors:  D A M Lyall; A Tey; B Foot; S T D Roxburgh; M Virdi; C Robertson; C J MacEwen
Journal:  Eye (Lond)       Date:  2012-10-12       Impact factor: 3.775

7.  Vitreous hemorrhage as the initial presentation of postoperative endophthalmitis.

Authors:  Asheesh Tewari; Enrique Garcia-Valenzuela; Dean Eliott
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

Review 8.  Virulence factors of Enterococcus faecalis: relationship to endodontic disease.

Authors:  Güven Kayaoglu; Dag Ørstavik
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

9.  Traumatic endophthalmitis presenting as isolated retinal vasculitis and white-centered hemorrhages: Case report and review of literature.

Authors:  Nidhi Relhan; Subhadra Jalali; Suma Nalamada; Vivek Dave; Annie Mathai
Journal:  Indian J Ophthalmol       Date:  2012-07       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.